News

Editorial

So you need a biopsy?

Certain clinical questions may instead be answered with a minimally invasive alternative: the liquid biopsy.

News

iCellate has been voted an organizational member of NACG

iCellate is pleased to announce that we has been voted an organizational member of NACG, the Nordic Alliance for Clinical Genomics.

News

iCellate is disrupting cancer care. Join us!

We now recruit for 3 new positions!

News

iCellate and Elthera consortium awarded with Eurostars grant of 25 MSEK for companion diagnostic development

News

iCellate has been selected by Novartis to participate in their Techcare program

News

iCellate hires - 3 new positions!

Come and join the iCellate team!

[Translate to English:]

News

iCellate welcomes VP of R&D, Åsa Rosenquist

News

Are you passionate about laboratory work, particularly microscopy?

iCellate’s fast-paced and agile team is growing. We hope you’ll join us in revolutionizing cancer care.

Research

Pioneering cancer diagnostic study, sponsored by iCellate and RCC Stockholm Gotland, is now enrolling patients

Could genetic tests be useful tools to classify cancer in early stages, even before symptoms occur?

News

Stockholm start-up ready to revolutionize cancer care

iCellate launches service to support oncologists in treatment selection for cancer patients.

Research

Study presented at KICancer - StratCan

Featured in

Cancer diagnostics via liquid biopsy

Article by SvD 2019-09-04

Featured in

iCellate honored as an EIT Health success story

News

iCellate is hiring an R&D Director

We are looking for a new R&D Director

News

Two new colleagues

Welcome Bonoshree and Sofia!

Research

The early detection of cancer study (ICELLATE1) – published in the Journal of Integrative Oncology

News

iCellate Medical raises 16 MSEK in new equity to demonstrate its clinical validity and utility

Research

Groundbreaking pan-cancer screening study published

Featured in

iCellate appears in DI

Research

iCellate enters partnership with RCC Stockholm-Gotland

News

New board appointed at extraordinary general meeting

News

Building for the future

New lab and office space in Hagalund

News

iCellate signs contract for new facility

News

iCellate Medical closes 15 million SEK second round of funding

News

IsoPic gets CE-approval

News

Pelle Redare, CEO, speaks at Karolinska Institute Science Park Day

News

iCellate Medical initiates a genetic sequencing project to further understand the causes of cancer

Research

New study in pancreas cancer together with Karolinska Institute

Research

New study in colorectal cancer together with Uppsala University

News

iCellate forms a team for the future

News

New grant: BIO-X support from Uppsala BIO

News

New cancer diagnostics project selected for BIO-X support in collaboration with Roche

News

New grant: Intellectual Property Right (IPR) strategy grant from the Swedish Incubators and Science Parks (SISP)